A chemiluminescent immunoassay for human serum osteocalcin, or bone Gla protein, was established using a double-antibody sandwich model. Examination of the hook effect revealed that it was significantly reduced, and no hook effect was observed at an osteocalcin concentration of 4000 ng/mL. The established method showed good analytical performance and thermal stability. The limit of detection was 0.03 ng/mL. The intra-assay coefficient of variation (CV) was 3.22%–5.64%, the interassay CV was 4.42%–7.25%, and the recovery rate was 93.22%–107.99%. Cross-reactivity (CR) was not observed with bovine, rat, mouse, rabbit, or porcine samples. The developed method showed a good correlation with the N-MID product from Roche. In total, 1069 clinical p...
Dsteocalcin RIA (Nichols). All of them presented accept-bIe values of variance, sensitivity,and seri...
The purposes of this study were threefold: (1) to compare values obtained by three conventional radi...
Serum samples from 9 healthy controls and from subjects with primary hyperparathyroidism (n = 5), Pa...
We developed a competitive chemiluminoimmunoassay of osteocalcin that is similar to radioimmunoassay...
marker for bone formation, but none of the commercial kits currently available can be used in automa...
A heterologous ELISA for measurement of osteocalcin (bone Gla-protein) is described, involvingbiotin...
We have developed and thoroughly validated a solid-phase sandwich enzyme-linked immunosorbent assay ...
We have developed and thoroughly validated radioimmu-noassays (AlAs) for osteocalcin in plasma and s...
In this solid-phase enzymoimmunoassay on microtiter plates for osteocalcinin serum or plasma, we use...
We describe a competitive enzyme immunoassay, the ExtrAvidin#{174}-biotinsystem, for determining ost...
BACKGROUND: Circulating human osteocalcin (hOC) has been used as a marker of bone formation. Our aim...
turnover, circulates in several forms. We developed an assay for intact human Oc and investigated it...
The study was designed to assess the sensitivity of three commercial assays (which differ in methodo...
been used as a marker of bone formation. Our aim was to validate three immunofluorometric assays (IF...
The purpose of this study was to estimate clinical validity of a new available immunoradiometric ass...
Dsteocalcin RIA (Nichols). All of them presented accept-bIe values of variance, sensitivity,and seri...
The purposes of this study were threefold: (1) to compare values obtained by three conventional radi...
Serum samples from 9 healthy controls and from subjects with primary hyperparathyroidism (n = 5), Pa...
We developed a competitive chemiluminoimmunoassay of osteocalcin that is similar to radioimmunoassay...
marker for bone formation, but none of the commercial kits currently available can be used in automa...
A heterologous ELISA for measurement of osteocalcin (bone Gla-protein) is described, involvingbiotin...
We have developed and thoroughly validated a solid-phase sandwich enzyme-linked immunosorbent assay ...
We have developed and thoroughly validated radioimmu-noassays (AlAs) for osteocalcin in plasma and s...
In this solid-phase enzymoimmunoassay on microtiter plates for osteocalcinin serum or plasma, we use...
We describe a competitive enzyme immunoassay, the ExtrAvidin#{174}-biotinsystem, for determining ost...
BACKGROUND: Circulating human osteocalcin (hOC) has been used as a marker of bone formation. Our aim...
turnover, circulates in several forms. We developed an assay for intact human Oc and investigated it...
The study was designed to assess the sensitivity of three commercial assays (which differ in methodo...
been used as a marker of bone formation. Our aim was to validate three immunofluorometric assays (IF...
The purpose of this study was to estimate clinical validity of a new available immunoradiometric ass...
Dsteocalcin RIA (Nichols). All of them presented accept-bIe values of variance, sensitivity,and seri...
The purposes of this study were threefold: (1) to compare values obtained by three conventional radi...
Serum samples from 9 healthy controls and from subjects with primary hyperparathyroidism (n = 5), Pa...